descovy

Generic: emtricitabine and tenofovir alafenamide

Labeler: gilead sciences, inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name descovy
Generic Name emtricitabine and tenofovir alafenamide
Labeler gilead sciences, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

emtricitabine 200 mg/1, tenofovir alafenamide fumarate 25 mg/1

Manufacturer
Gilead Sciences, Inc.

Identifiers & Regulatory

Product NDC 61958-2002
Product ID 61958-2002_12aff732-63cd-4d90-a329-7c3851e6b966
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA208215
Listing Expiration 2026-12-31
Marketing Start 2016-04-04

Pharmacologic Class

Established (EPC)
human immunodeficiency virus nucleoside analog reverse transcriptase inhibitor [epc]
Mechanism of Action
nucleoside reverse transcriptase inhibitors [moa]
Chemical Structure
nucleosides [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 619582002
Hyphenated Format 61958-2002

Supplemental Identifiers

RxCUI
1747691 1747697 2590641 2590643
UNII
FWF6Q91TZO G70B4ETF4S
NUI
N0000175462 M0015066 N0000009947

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name descovy (source: ndc)
Generic Name emtricitabine and tenofovir alafenamide (source: ndc)
Application Number NDA208215 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 200 mg/1
  • 25 mg/1
source: ndc
Packaging
  • 30 TABLET in 1 BOTTLE, PLASTIC (61958-2002-1)
  • 30 TABLET in 1 BLISTER PACK (61958-2002-2)
source: ndc

Packages (2)

61958-2002-1 30 TABLET in 1 BOTTLE, PLASTIC (61958-2002-1) 61958-2002-2 30 TABLET in 1 BLISTER PACK (61958-2002-2)

Ingredients (2)

emtricitabine (200 mg/1) tenofovir alafenamide fumarate (25 mg/1)

Linked Drug Pages (1)

DESCOVY ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "12aff732-63cd-4d90-a329-7c3851e6b966", "openfda": {"nui": ["N0000175462", "M0015066", "N0000009947"], "unii": ["FWF6Q91TZO", "G70B4ETF4S"], "rxcui": ["1747691", "1747697", "2590641", "2590643"], "spl_set_id": ["06f66e98-e6ee-4538-9506-6c1282cc14c1"], "pharm_class_cs": ["Nucleosides [CS]"], "pharm_class_epc": ["Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["Gilead Sciences, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE, PLASTIC (61958-2002-1)", "package_ndc": "61958-2002-1", "marketing_start_date": "20160404"}, {"sample": false, "description": "30 TABLET in 1 BLISTER PACK (61958-2002-2)", "package_ndc": "61958-2002-2", "marketing_start_date": "20200122"}], "brand_name": "DESCOVY", "product_id": "61958-2002_12aff732-63cd-4d90-a329-7c3851e6b966", "dosage_form": "TABLET", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleosides [CS]", "Nucleosides [CS]"], "product_ndc": "61958-2002", "generic_name": "emtricitabine and tenofovir alafenamide", "labeler_name": "Gilead Sciences, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "DESCOVY", "active_ingredients": [{"name": "EMTRICITABINE", "strength": "200 mg/1"}, {"name": "TENOFOVIR ALAFENAMIDE FUMARATE", "strength": "25 mg/1"}], "application_number": "NDA208215", "marketing_category": "NDA", "marketing_start_date": "20160404", "listing_expiration_date": "20261231"}